Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10785.25 49.80 0.46%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Virax Holdings Ltd (ASX: VHL)

 
VHL Technical Analysis
5
As on 12th Dec 2014 VHL Share Price closed @ 0.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VHL Share Price

Open 0.14 Change Price %
High 0.14 1 Day 0.00 0.00
Low 0.14 1 Week 0.00 0.00
Close 0.14 1 Month 0.00 0.00
Volume 22950 1 Year 0.00 0.00
52 Week High 1.60 | 52 Week Low 1.48
 
ASX Australia Most Active Stocks
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
BPT 1.05 7.14%
PNX 0.01 0.00%
PIO 0.03 0.00%
DJS 3.99 0.00%
KSO 0.40 3900.00%
 
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
 
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
 
 
VHL
Daily Charts		 VHL
Intraday Charts		 Whats New @
Bazaartrend		 VHL
Free Analysis
 
VHL Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
SUPPORT0.00
SUPPORT0.00
 
VHL Target for Month February
Share
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
VHL Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
VHL Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
VHL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.virax.com.au
 
VHL Address
VHL
 Kew Junction Tower
Suite 220
Kew, VIC 3101
Australia
Phone: 61 3 9854 6230
Fax: 61 3 9853 5134
 
VHL Latest News
 
Your Comments and Response on Virax Holdings Ltd
 
VHL Business Profile
Virax Holdings Limited, a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer in Australia. It primarily develops immunotherapeutics based on its Co-X-Gene and fowlpox virus delivery technologies. The companyÂ’s Co-X-Gene based vaccines are used for the treatment of HIV, hepatitis B virus, and prostate cancer. Its lead product includes VIR201, an HIV/AIDS immunotherapeutic product, which has completed two Phase I/IIa clinical trials. The company also develops VIR501, a therapeutic prostate cancer vaccine; and therapeutic human papilloma virus (HPV) vaccine. In addition, it licenses its technology to produce immunotherapeutic products, including TG4001, a cancer vaccine that has completed Phase IIb CIN2/3/HPV trial; and TG4010, a lung cancer vaccine, which has completed Phase IIb trial. Virax Holdings Limited is based in Kew, Australia.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service